Pneumococcal infectious aortic aneurysm: A caution for a life-threatening vascular complication caused by non-vaccine-covered serotypes.
Infectious aortic aneurysm
Invasive pneumococcal disease
Mycotic aortic aneurysm
Non-vaccine-covered serotype
Streptococcus pneumoniae
Journal
Journal of cardiology cases
ISSN: 1878-5409
Titre abrégé: J Cardiol Cases
Pays: Japan
ID NLM: 101549579
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
08
04
2023
revised:
16
08
2023
accepted:
17
08
2023
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
8
1
2024
Statut:
epublish
Résumé
The 23-valent pneumococcal polysaccharide vaccine (PPSV23) has contributed to reducing pneumonia caused by •To be able to make a differential diagnosis of invasive pneumococcal pneumonia in patients with persistent fever and newly emerging back pain following pneumococcal infection.•To understand the importance of combining culture tests and molecular analysis to diagnose invasive pneumococcal diseases accurately.•To understand the threat of non-vaccine-covered serotypes even in patients with vaccination histories because the vaccine is limited to only one-fourth of all pneumococcal serotypes.
Identifiants
pubmed: 38188312
doi: 10.1016/j.jccase.2023.08.015
pii: S1878-5409(23)00106-8
pmc: PMC10770090
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1-4Informations de copyright
© 2023 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.